Objective. Tumor angiogenesis is a highly regulated process under the influ
ence of the host microenvironment and mediators. Studies of breast cancer a
nd, more recently, ovarian and cervical cancer, demonstrate that neovascula
rization correlates with the likelihood of metastasis and recurrence. Vascu
lar endothelial growth factor (VEGF), an important regulator of tumor angio
genesis in the endometrium, flt-1, and KDR/flk-1 are good markers of vascul
ar proliferation. Being that angiogenesis is a precursor to the development
of progressive disease, we hypothesize that quantifying VEGF, flt-1, and K
DR/flk-1 expression in uterine malignancies is a superior predictor of meta
static potential and survival than is FIGO grade of tumor, depth of invasio
n, and histology.
Methods. The histologic slides of 47 patients with uterine malignancies (35
adenocarcinomas, 6 papillary serous, and 6 carcinosarcomas) were reviewed.
The paraffin blocks from the primary tumor were obtained. Immunohistochemi
stry staining was performed for VEGF, flt-1, and KDR/flk-1. Microvessel den
sity, used to analyze VEGF and receptor concentrations, was determined by t
wo independent investigators, who were blinded to the patients clinical sta
tus. The impact of VEGF, flt-1, and KDR/flk-1 as well as stage, grade, dept
h of invasion, and nodal status on the incidence of metastases, recurrence,
and survival was determined using logistic regression analysis and product
limit life system survival analysis, respectively.
Results. Results indicated that when evaluating all three histologic types,
only stage and grade of tumor were found to impact upon the incidence of r
ecurrence and survival. When patients with carcinosarcoma and papillary ser
ous adenocarcinoma were excluded from the analysis, once again only stage a
nd grade of tumor were significant prognostic indicators of recurrence and
survival. Only grade of tumor and depth of uterine invasion were significan
t predictors of a tumor's metastatic potential. VEGF, flt-1, and KDR/flk-1
proved to be of little significance in predicting metastases, recurrence, a
nd survival. Patients with advanced disease in all three histologic subtype
s often had low VEGF and receptor positivity.
Conclusions. In this study, VEGF, flt-1, and KDR/flk-1 receptor concentrati
ons did not correlate with the incidence of metastases, recurrence, and sur
vival. (C) 2000 Academic Press.